M

Are Analysts Underestimating Macy's (M)?

Macy's may be undervalued with poor growth indicators, but the 12 analysts following the company give it an rating of hold. Their target prices range from $11.0 to $19.0 per share, for an average of $14.75. At today's price of $20.27, Macy's is trading 37.42% away from its average target price, suggesting there is an analyst belief that shares are overpriced for the stock.

Macy's, Inc., an omni-channel retail organization, operates stores, websites, and mobile applications in the United States. Based in New York, NY, the mid-cap Consumer Discretionary company has 94,570 full time employees. Macy's has provided a 3.8% dividend yield over the last 12 months.

Macy's has a trailing twelve month P/E ratio of 8.3, compared to an average of 22.96 for the Consumer Discretionary sector. Considering its EPS guidance of $2.74, the company has a forward P/E ratio of 7.4.

The average compound growth rate of the company's historical and projected earnings per share is -8.5%. On this basis, the company's PEG ratio is -0.62, which indicates that its shares are overpriced.

On the other hand, the market is potentially undervaluing Macy's in terms of its book value because its P/B ratio is 1.34. In comparison, the sector average P/B ratio is 4.24. The company's shares are currently -46.6% below their Graham number, indicating that its shares have a margin of safety.

If analysts are giving the the company a mediocre rating despite its low valuation point, it could be related to the company's disappointing cash flows. Furthermore, Macy's has poor margins as you can see in the financial summary below.

2018 2019 2020 2021 2022 2023
Revenue (MM) $24,837 $24,971 $24,560 $17,346 $24,460 $24,442
Revenue Growth n/a 0.54% -1.65% -29.37% 41.01% -0.07%
Gross Margins 39% 39% 38% 28% 39% 37%
Operating Margins 8% 7% 4% -26% 10% 7%
Net Interest Expense (MM) $321 $261 $205 $284 $256 $175
Depreciation & Amort. (MM) $991 $962 $981 $959 $874 $857
Earnings Per Share $5.1 $3.56 $1.81 -$12.68 $4.55 $4.19
EPS Growth n/a -30.2% -49.16% -800.55% 135.88% -7.91%
Diluted Shares (MM) 307 311 311 311 314 281
Free Cash Flow (MM) $1,489 $1,078 $636 $311 $2,358 $727
Capital Expenditures (MM) $487 $657 $972 $338 $354 $888
Current Ratio 1.34 1.28 1.11 1.14 1.09 1.26
Long Term Debt (MM) $5,469 $4,677 $4,852 $3,295 $2,996 $2,997
Net Debt / EBITDA 2.54 2.21 2.77 -0.89 0.88 0.99
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS